WASHINGTON, D.C. – Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on today’s mark up in the House Ways & Means Committee of legislation (HR 160) to repeal the medical device tax:
“AdvaMed commends Chairman Paul Ryan (R-Wis.), Rep. Erik Paulsen (R-Minn.), Rep. Ron Kind (D-Wisc.) and the rest of the members of the committee for their leadership in moving forward bipartisan legislation to eliminate a significant obstacle to the development of next-generation advancements in medical technology.
“Today’s mark up represents a key milestone in the repeal of a tax that has already had a detrimental effect on medical progress. American patients are depending on the next generation of breakthrough technologies to become a reality. With an aging population and chronic disease growing at ever-faster rates, now is the time for more – not less – resources to advance cures and treatments to help people live healthier, more independent lives.
“There is strong bipartisan support in both chambers of Congress to repeal this anti-patient, anti-innovation tax. We look forward to the full House taking up repeal legislation in the near future, and we urge the Senate to follow suit.”
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.